Skip to main content
Medy-Tox Inc. logo

Medy-Tox Inc. — Investor Relations & Filings

Ticker · 086900 ISIN · KR7086900008 KO Manufacturing
Open in API
Filings indexed 414 across all filing types
Latest filing 2025-07-22 Transaction in Own Shar…
Country KR South Korea
Listing KO 086900

About Medy-Tox Inc.

https://www.medytox.com/?site_id=en

Medy-Tox Inc. is a biopharmaceutical company focused on the research, development, and commercialization of biologic products. Its primary offerings are centered on botulinum toxin type A (BTX-A) formulations, including Neuronox®, INNOTOX®, Coretox®, and NEWLUX®, which are used for both aesthetic and therapeutic applications. The company is noted for developing the world's first liquid-injectable botulinum toxin. In addition to its toxin portfolio, Medy-Tox manufactures and markets a line of hyaluronic acid (HA) dermal fillers, such as Neuramis®, Atiere, and Potenfill. The company's product range also extends to dermocosmetics under the NEURADERM brand.

Recent filings

Filing Released Lang Actions
자기주식처분결과보고서
Transaction in Own Shares Classification · 1% confidence The document is a 'Report on the Results of Disposal of Treasury Shares' (자기주식처분결과보고서) filed by Medytox with the Financial Supervisory Service of South Korea. It details the specific disposal of treasury shares resulting from the exercise of stock options. This falls under the category of a company reporting its own share transactions, which is classified as 'Transaction in Own Shares' (POS).
2025-07-22 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares Classification · 1% confidence The document is a 'Major Matters Report' (주요사항보고서) from Medytox, specifically detailing a 'Decision to Dispose of Treasury Shares' (자기주식 처분 결정) due to the exercise of stock options. This type of regulatory filing in the Korean market, which reports on the company's own share transactions (disposal/buyback), falls under the 'Transaction in Own Shares' category.
2025-07-16 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서) filed by the National Pension Service of Korea regarding their stake in Medytox. This type of filing is a regulatory requirement when an entity crosses a specific ownership threshold (typically 5%) in a publicly traded company. In the provided taxonomy, this corresponds to a 'Major Shareholding Notification'.
2025-07-02 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for the company Medytox, covering the period from January 1, 2025, to March 31, 2025. It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-14 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 1% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Medytox, detailing quarterly financial performance (2025.1Q) including revenue, operating profit, and net income. It is a standard initial announcement of financial results, which fits the definition of an Earnings Release (ER). Q1 2025
2025-05-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a standard regulatory requirement for directors or major shareholders to disclose their personal shareholdings and changes therein. According to the provided definitions, this falls under 'Director's Dealing' (DIRS), which covers personal share transactions and ownership reports by company directors and executives.
2025-04-09 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.